Position in SCLX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$39
-$36,986 QoQ
Shares Held
6
-99.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 83%
Shared 0%
None 17%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026JPMORGAN CHASE & CO holds $65,165,946,867 across 18 Drug Manufacturers - General names. SCLX ranks #18 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
63,096,344 | $15,423,270,317 | |
| 2 | LLY |
ELI LILLY & Co
|
13,698,491 | $12,599,461,057 | |
| 3 | ABBV |
AbbVie Inc.
|
56,741,691 | $12,340,750,365 | |
| 4 | MRK |
Merck & Co., Inc.
|
52,972,983 | $6,372,120,116 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
92,475,194 | $5,608,620,506 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
33,992,410 | $4,737,522,172 | |
| 7 | AZN |
Astrazeneca PLC
|
18,590,922 | $3,666,501,627 | |
| 8 | AMGN |
Amgen Inc
|
7,277,837 | $2,560,706,939 |
All Filings in SCLX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $39 | 6 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $37,025 | 3,035 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $117 | 6 | Shares | Defined | 2025-11-26 | |
| 2025-06-30 | $34 | 6 | Shares | Defined | 2025-08-12 | |
| No filing history on record for this holder in this stock. | ||||||